Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 14/20 | 0.46 |
| ▸ | CNR2 | P34972 | 9/20 | 0.46 |
| ▸ | CTSK | P43235 | 2/20 | 0.45 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14064688 | 0.95 | CTSK (0.48) | PTGER4CNR1CNR2CTSKFDFT1 | |
| SCHEMBL4827977 | 0.95 | CTSK (0.48) | PTGER4CNR1CNR2CTSKFDFT1 | |
| SCHEMBL14064696 | 0.93 | PTGER4 (0.50) | PTGER4CNR1CNR2CTSKFDFT1 | |
| SCHEMBL4825437 | 0.93 | PTGER4 (0.50) | PTGER4CNR1CNR2CTSKFDFT1 | |
| Trifluoroacetic Acid SCHEMBL4831463 | 0.87 | CNR1 (0.46) | CNR1CNR2FDFT1 | |
| SCHEMBL4829838 | 0.81 | CNR1 (0.48) | PTGER4CNR1CNR2FDFT1 | |
| SCHEMBL14064682 | 0.81 | CNR1 (0.48) | PTGER4CNR1CNR2FDFT1 | |
| Trifluoroacetic Acid SCHEMBL4829894 | 0.79 | CNR1 (0.48) | CNR1CNR2FDFT1 | |
| Trifluoroacetic Acid SCHEMBL30859244 | 0.77 | ELANE (0.50) | PTGER4CNR2 | |
| SCHEMBL4827963 | 0.75 | CNR1 (0.50) | CNR1CNR2FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7423067-B2 | N-(3,4-diphenyl-2-butyl)cyclopentancarboxamide derivatives such as N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-3-benzoyl-cyclopentane-carboxamide; used for treating conditions including psychological disorders, eating disorders and substance abuse | MERCK & CO., INC. (US) | 2008-09-09 | — | — | US | disclosed |